AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 76-100/103
Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease
Authors: Yousef, GM Luo, LY Scherer, SW Sotiropoulou, G Diamandis, EP
Citation: Gm. Yousef et al., Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease, GENOMICS, 62(2), 1999, pp. 251-259
Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2
Authors: Zand, RSR Jenkins, DJA Diamandis, EP
Citation: Rsr. Zand et al., Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2, J CL LAB AN, 13(5), 1999, pp. 241-245
Amplification of human genomic DNA sequences with polymerase chain reaction using a single oligonucleotide primer
Authors: Luo, LY Diamandis, EP
Citation: Ly. Luo et Ep. Diamandis, Amplification of human genomic DNA sequences with polymerase chain reaction using a single oligonucleotide primer, J CL LAB AN, 13(2), 1999, pp. 69-74
Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease
Authors: Borchert, GH Yu, H Tomlinson, G Giai, M Roagna, R Ponzone, R Sgro, L Diamandis, EP
Citation: Gh. Borchert et al., Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease, J CL LAB AN, 13(2), 1999, pp. 75-81
Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4
Authors: Yousef, GM Luo, LY Diamandis, EP
Citation: Gm. Yousef et al., Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4, ANTICANC R, 19(4B), 1999, pp. 2843-2852
Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma
Authors: Lianidou, ES Levesque, MA Katsaros, D Angelopoulov, K Yu, H Genta, F Arisio, R Massobrio, M Bharaj, B Diamandis, EP
Citation: Es. Lianidou et al., Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma, ANTICANC R, 19(1B), 1999, pp. 749-756
Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy
Authors: Wald, NJ Hackshaw, AK Diamandis, EP Melegos, DN
Citation: Nj. Wald et al., Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy, PRENAT DIAG, 19(7), 1999, pp. 674-676
Beta-trace protein as indicator of glomerular filtration rate - Reply
Authors: Diamandis, EP
Citation: Ep. Diamandis, Beta-trace protein as indicator of glomerular filtration rate - Reply, UROLOGY, 54(5), 1999, pp. 941-941
Characterization of the BRCA1-like immunoreactivity of human seminal plasma
Authors: Angelopoulou, K Borchert, G Melegos, DN Lianidou, E Lilja, H Diamandis, EP
Citation: K. Angelopoulou et al., Characterization of the BRCA1-like immunoreactivity of human seminal plasma, UROLOGY, 54(4), 1999, pp. 753-762
Seminal plasma biochemical markers and their association with semen analysis findings
Authors: Diamandis, EP Arnett, WP Foussias, G Pappas, H Ghandi, S Melegos, DN Mullen, B Yu, H Srigley, J Jarvi, K
Citation: Ep. Diamandis et al., Seminal plasma biochemical markers and their association with semen analysis findings, UROLOGY, 53(3), 1999, pp. 596-603
Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure
Authors: Melegos, DN Grass, L Pierratos, A Diamandis, EP
Citation: Dn. Melegos et al., Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure, UROLOGY, 53(1), 1999, pp. 32-37
The new kallikrein-like gene, KLK-L2 - Molecular characterization, mapping, tissue expression, and hormonal regulation
Authors: Yousef, GM Diamandis, EP
Citation: Gm. Yousef et Ep. Diamandis, The new kallikrein-like gene, KLK-L2 - Molecular characterization, mapping, tissue expression, and hormonal regulation, J BIOL CHEM, 274(53), 1999, pp. 37511-37516
Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen
Authors: Black, MH Magklara, A Obiezu, CV Melegos, DN Diamandis, EP
Citation: Mh. Black et al., Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen, CLIN CHEM, 45(6), 1999, pp. 790-799
Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays
Authors: Black, MH Grass, CL Leinonen, J Stenman, UH Diamandis, EP
Citation: Mh. Black et al., Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays, CLIN CHEM, 45(3), 1999, pp. 347-354
The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA
Authors: Magklara, A Scorilas, A Catalona, WJ Diamandis, EP
Citation: A. Magklara et al., The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA, CLIN CHEM, 45(11), 1999, pp. 1960-1966
Human glandular kallikrein in breast milk, amniotic fluid, and breast cystfluid
Authors: Magklara, A Scorilas, A Lopez-Otin, C Vizoso, F Ruibal, A Diamandis, EP
Citation: A. Magklara et al., Human glandular kallikrein in breast milk, amniotic fluid, and breast cystfluid, CLIN CHEM, 45(10), 1999, pp. 1774-1780
Rapid and accurate determination of (CAG)(n) repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis
Authors: Bharaj, BS Vassilikos, EJK Diamandis, EP
Citation: Bs. Bharaj et al., Rapid and accurate determination of (CAG)(n) repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis, CLIN BIOCH, 32(5), 1999, pp. 327-332
Fragment analysis of the p53 gene in ovarian tumors (vol 31, pg 551, 1998)
Authors: Lianidous, ES Angelopoulou, K Katsaros, D Durando, A Massobrio, M Diamandis, EP
Citation: Es. Lianidous et al., Fragment analysis of the p53 gene in ovarian tumors (vol 31, pg 551, 1998), CLIN BIOCH, 32(2), 1999, pp. 155-155
Quantification of pepsinogen C and prostaglandin D synthase in breast cystfluid and their potential utility for cyst type classification
Authors: Borchert, GH Melegos, DN Yu, H Giai, M Roagna, R Ponzone, R Sgro, L Diamandis, EP
Citation: Gh. Borchert et al., Quantification of pepsinogen C and prostaglandin D synthase in breast cystfluid and their potential utility for cyst type classification, CLIN BIOCH, 32(1), 1999, pp. 39-44
Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated
Authors: Yousef, GM Obiezu, CV Luo, LY Black, MH Diamandis, EP
Citation: Gm. Yousef et al., Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated, CANCER RES, 59(17), 1999, pp. 4252-4256
Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma
Authors: Diamandis, EP Helle, SI Yu, H Melegos, DN Lundgren, S Lonning, PE
Citation: Ep. Diamandis et al., Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma, CANCER, 85(4), 1999, pp. 891-898
Enhanced prediction of breast cancer prognosis by evaluating expression ofp53 and prostate-specific antigen in combination
Authors: Yu, H Levesque, MA Clark, GM Diamandis, EP
Citation: H. Yu et al., Enhanced prediction of breast cancer prognosis by evaluating expression ofp53 and prostate-specific antigen in combination, BR J CANC, 81(3), 1999, pp. 490-495
The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines
Authors: Majumdar, S Diamandis, EP
Citation: S. Majumdar et Ep. Diamandis, The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines, BR J CANC, 79(9-10), 1999, pp. 1594-1602
Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer
Authors: Foekens, JA Diamandis, EP Yu, H Look, MP Meijer-van Gelder, ME van Putten, WLJ Klijn, JGM
Citation: Ja. Foekens et al., Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer, BR J CANC, 79(5-6), 1999, pp. 888-894
Elevated estradiol and testosterone levels and risk for breast cancer
Authors: Yu, H Diamandis, EP Hoffman, B
Citation: H. Yu et al., Elevated estradiol and testosterone levels and risk for breast cancer, ANN INT MED, 131(9), 1999, pp. 715-715
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>